Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 17/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4631308 | 0.77 | HCAR2 (0.63) | HCAR2DAO | |
| SCHEMBL7234538 | 0.76 | HCAR2 (0.57) | HCAR2KMT2ADAOTSHR | |
| SCHEMBL17065994 | 0.74 | HCAR2 (0.55) | HCAR2KMT2ADAOTSHR | |
| SCHEMBL15859525 | 0.74 | HCAR2 (0.55) | HCAR2KMT2ADAOTSHR | |
| SCHEMBL29954524 | 0.74 | HCAR2 (0.59) | HCAR2DAO | |
| SCHEMBL31741716 | 0.74 | HCAR2 (0.59) | HCAR2KMT2ADAOTSHR | |
| SCHEMBL2543083 | 0.74 | HCAR2 (0.59) | HCAR2KMT2ATSHR | |
| SCHEMBL11094727 | 0.74 | ALDH1A1 (0.41) | KMT2ATSHR | |
| SCHEMBL4877467 | 0.72 | HCAR2 (0.53) | HCAR2KMT2ADAOTSHR | |
| SCHEMBL29956356 | 0.72 | HCAR2 (0.53) | HCAR2KMT2ADAOTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103068842-B | Insulin receptor INSR is had highly active single-chain insulin agonist | 印第安纳大学研究及科技有限公司 | 2016-10-19 | — | — | CN | disclosed |
| CN-103068842-A | Single chain insulin agonists exhibiting high activity at the insulin receptor | UNIV INDIANA RES & TECH CORP | 2013-04-24 | — | — | CN | disclosed |
| US-20110262397-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CONTROL OF HEPATITIS C VIRAL INFECTIONS | APATH, LLC (US) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262397-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CONTROL OF HEPATITIS C VIRAL INFECTIONS | HAVCR2, FABP1, HCCS | HCAR2 2570/4885KMT2A 4066/4885DAO 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.